Please note that masks are still required at our clinic locations to reduce possible exposure to COVID-19 for at-risk patients.

If you have flu-like symptoms, you should contact Florida Cancer Affiliates before visiting our clinics for scheduled appointments. This includes fever and symptoms of respiratory illness, such as coughing or difficulty breathing.

Location & Physicians


Steven Finkelstein, M.D., DABR, FACRO

Steven Finkelstein, M.D., DABR, FACRO


Panama City

2100 State Avenue
Panama City , FL 32405


Medical School

University of Michigan


Radiation Oncology at Moffitt Cancer Center, University of South Florida


National Cancer Institute, National Institutes of Health


Steven Eric Finkelstein received his M.D. from the University of Michigan in 1997 graduating cum laude eruditions causa. He joined the National Cancer Institute (NCI), National Institutes of Health (NIH) as Clinical Associate in 1999 and completed both Surgical Oncology Fellowship as well as Clinical Immunotherapy Fellowship in 2004. Following completion of an additional radiation oncology residency, Dr. Finkelstein was selected as Chief Resident in Radiation Oncology at Moffitt Cancer Center / University of South Florida. In 2011, he was recruited to join the 21C Translational Research Consortium (TRC) and was appointed its National Director. In 2014, he was promoted to 21C Chief Science Officer. In 2017, he returned to Florida to serve as Cancer Director of Bay Regional Cancer Center at AUI.

In 2019, with much excitement Dr. Finkelstein has joined the US Oncology Network at Florida Cancer Affiliates and looks to continue forward to continue advancing patient access to novel, advanced cancer care.

Dr. Finkelstein has a special interest in the study and patient care and research of a variety of cancers, using radiation driven, and personalized systemic therapy. Accordingly, he holds three International patents pending in the field of “cutting edge” technologies.

Dr. Finkelstein has given national and international lectures, published numerous professional journal articles and written book chapters, resulting in over 8000 reference citations. He also serves on the editorial board of key international journals including the American Society of Clinical Oncology (ASCO) as the ASCO Associate Editor for Immunotherapy.

For these contributions to patients, Dr. Finkelstein was one of the youngest physicians to receive accelerated fellowship in the American College of Radiation Oncology (ACRO) in 2017 and elected to the ACRO Board of Chancellors and Chair of Education in 2018.